tradingkey.logo
tradingkey.logo
Buscar

Simulations Plus Inc

SLP
Añadir a la lista de seguimiento
18.390USD
+0.040+0.22%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
370.50MCap. mercado
PérdidaP/E TTM

Más Datos de Simulations Plus Inc Compañía

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.

Información de Simulations Plus Inc

Símbolo de cotizaciónSLP
Nombre de la empresaSimulations Plus Inc
Fecha de salida a bolsaJun 18, 1997
Director ejecutivoO'Connor (Shawn M)
Número de empleados212
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 18
Dirección800 Park Offices Drive, Suite 401
CiudadRESEARCH TRIANGLE PARK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal27709
Teléfono16617237723
Sitio Webhttps://www.simulations-plus.com/
Símbolo de cotizaciónSLP
Fecha de salida a bolsaJun 18, 1997
Director ejecutivoO'Connor (Shawn M)

Ejecutivos de Simulations Plus Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.25M
-0.46%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Ms. Jenna Rouse
Ms. Jenna Rouse
Global Head - Clinical Operations
Global Head - Clinical Operations
--
--
Mr. Murry Alper
Mr. Murry Alper
Global Head - Medical Communications
Global Head - Medical Communications
--
--
Ms. Lisa Fortuna
Ms. Lisa Fortuna
Investor Relations
Investor Relations
--
--
Mr. Josh Fohey
Mr. Josh Fohey
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Erik Guffrey
Mr. Erik Guffrey
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.25M
-0.46%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Ms. Jenna Rouse
Ms. Jenna Rouse
Global Head - Clinical Operations
Global Head - Clinical Operations
--
--
Mr. Murry Alper
Mr. Murry Alper
Global Head - Medical Communications
Global Head - Medical Communications
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Simulations Plus Inc?

Los cinco principales accionistas de Simulations Plus Inc son: Dr. Hon. Walter S. Woltosz

¿Cuántas instituciones poseen acciones de Simulations Plus Inc (SLP)?

A fecha de 2026Q1, 432 instituciones poseen acciones de Simulations Plus Inc, con un valor de mercado combinado de aproximadamente 17.68M, lo que representa el 87.48% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -4627215.00.

¿Cuál es la mayor fuente de ganancias de Simulations Plus Inc?

El 2026Q1, el segmento empresarial Consulting services generó la ganancia más alta para Simulations Plus Inc, ascendiendo a 9.54M y representando el 51.78% de la ganancia total.